The government has announced new funding of up to £86 million for UK firms to develop medical breakthroughs. The package will allow small and medium sized enterprises (SMEs) to develop and test new technologies in the NHS.
Commenting on the announcement, Keith Thompson, CEO, Cell and Gene Therapy Catapult said,
It is great to see that the UK Government is supporting innovation in the NHS. The £86 million funding will enable SMEs to access the fantastic asset that is the NHS, enabling new technologies to get from the lab to patients faster.
Funding such as this, supporting innovation in the life sciences, will support the UK’s goal to be a world leader in the industry.
The full announcement can be found on the Department of Health and Department for Business, Energy and Industrial Strategy websites.
Response from the UK BioIndustry Association can be found on the UK BioIndustry Association website.